Well well...……., looks like David Suhy hasn't left the building after all and our Hep B program can now be counted with BB 401, BB 501, OPMD, AMD, the new Benitec Proprietary program to be announced shortly and the 5 Axovant gene therapy programs. Benitec is the next Alnylam but the market doesn't know it yet. Patrick Soon-Shiong knows and he bought a third of the company.
BLT Price at posting:
14.0¢ Sentiment: Buy Disclosure: Held